virus |
thing |
pathway |
SARS-CoV-2 (edit) |
ORF9c protein [SARS CoV-2] (edit) |
Mitochondrial immune response to SARS-CoV-2 (edit) |
SARS-CoV-2 (edit) |
S1 Subunit of Spike Protein (edit) |
Mitochondrial immune response to SARS-CoV-2 (edit) |
SARS-CoV-2 (edit) |
S1 Subunit of Spike Protein (edit) |
SARS-CoV-2 innate immunity evasion and cell-specific immune response (edit) |
SARS-CoV-2 (edit) |
S1 Subunit of Spike Protein (edit) |
SARS-CoV-2 altering angiogenesis via NRP1 (edit) |
SARS-CoV-2 (edit) |
S1 Subunit of Spike Protein (edit) |
Soluble ACE2-mediated cell entry of SARS-CoV-2 (edit) |
SARS-CoV-2 (edit) |
S2 Subunit of Spike Protein (edit) |
Mitochondrial immune response to SARS-CoV-2 (edit) |
SARS-CoV-2 (edit) |
S2 Subunit of Spike Protein (edit) |
SARS-CoV-2 altering angiogenesis via NRP1 (edit) |
SARS-CoV-2 (edit) |
S2 Subunit of Spike Protein (edit) |
SARS-CoV-2 en COVID-19 pathway (edit) |
SARS-CoV-2 (edit) |
Non-structural protein 10 [SARS CoV-2] (edit) |
A draft map of SARS-COV-2 signaling pathway map (edit) |
SARS-CoV-2 (edit) |
Non-structural protein 10 [SARS CoV-2] (edit) |
SARS-CoV-2 en COVID-19 pathway (edit) |
SARS-CoV-2 (edit) |
Non-structural protein 10 [SARS CoV-2] (edit) |
Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex (edit) |
SARS-CoV-2 (edit) |
non-structural protein 15 [SARS-CoV-2] (edit) |
SARS-CoV-2 en COVID-19 pathway (edit) |
SARS-CoV-2 (edit) |
non-structural protein 15 [SARS-CoV-2] (edit) |
Endoplasmic reticulum stress response in coronavirus infection (edit) |
SARS-CoV-2 (edit) |
Papain-like proteinase [SARS-CoV-2] (edit) |
Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway (edit) |
SARS-CoV-2 (edit) |
Papain-like proteinase [SARS-CoV-2] (edit) |
SARS-CoV-2 en COVID-19 pathway (edit) |
SARS-CoV-2 (edit) |
non-structural protein 5 [SARS-CoV-2] (edit) |
Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway (edit) |
SARS-CoV-2 (edit) |
non-structural protein 5 [SARS-CoV-2] (edit) |
SARS-CoV-2 en COVID-19 pathway (edit) |
SARS-CoV-2 (edit) |
surface glycoprotein (edit) |
SARS-CoV-2 en COVID-19 pathway (edit) |
SARS-CoV-2 (edit) |
ORF1a polyprotein;ORF1ab polyprotein (edit) |
Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway (edit) |
SARS-CoV-2 (edit) |
ORF1a polyprotein;ORF1ab polyprotein (edit) |
SARS-CoV-2 en COVID-19 pathway (edit) |
SARS-CoV-2 (edit) |
ORF3a protein (edit) |
SARS-CoV-2 en COVID-19 pathway (edit) |
SARS-CoV-2 (edit) |
envelope protein (edit) |
SARS-CoV-2 en COVID-19 pathway (edit) |
SARS-CoV-2 (edit) |
membrane glycoprotein (edit) |
SARS-CoV-2 en COVID-19 pathway (edit) |
SARS-CoV-2 (edit) |
ORF6 protein (edit) |
SARS-CoV-2 B.1.1.7 variant antagonises innate immune activation (edit) |
SARS-CoV-2 (edit) |
ORF6 protein (edit) |
SARS-CoV-2 en COVID-19 pathway (edit) |
SARS-CoV-2 (edit) |
ORF7a protein (edit) |
SARS-CoV-2 en COVID-19 pathway (edit) |
SARS-CoV-2 (edit) |
ORF7b (edit) |
SARS-CoV-2 en COVID-19 pathway (edit) |
SARS-CoV-2 (edit) |
ORF8 protein (edit) |
SARS-CoV-2 en COVID-19 pathway (edit) |
SARS-CoV-2 (edit) |
nucleocapsid phosphoprotein (edit) |
SARS-CoV-2 B.1.1.7 variant antagonises innate immune activation (edit) |
SARS-CoV-2 (edit) |
nucleocapsid phosphoprotein (edit) |
SARS-CoV-2 en COVID-19 pathway (edit) |
SARS-CoV-2 (edit) |
ORF10 protein (edit) |
SARS-CoV-2 en COVID-19 pathway (edit) |
SARS-CoV-2 (edit) |
Non-structural protein 6 [SARS-CoV-2] (edit) |
SARS-CoV-2 en COVID-19 pathway (edit) |
SARS-CoV-2 (edit) |
ORF7a protein (edit) |
SARS-CoV-2 en COVID-19 pathway (edit) |
SARS-CoV-2 (edit) |
Non-structural protein 8 [SARS-CoV-2] (edit) |
Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway (edit) |
SARS-CoV-2 (edit) |
Non-structural protein 8 [SARS-CoV-2] (edit) |
SARS-CoV-2 en COVID-19 pathway (edit) |
SARS-CoV-2 (edit) |
Non-structural protein 2 [SARS CoV-2] (edit) |
SARS-CoV-2 en COVID-19 pathway (edit) |
SARS-CoV-2 (edit) |
ORF6 protein (edit) |
SARS-CoV-2 en COVID-19 pathway (edit) |
SARS-CoV-2 (edit) |
ORF10 protein (edit) |
SARS-CoV-2 en COVID-19 pathway (edit) |
SARS-CoV-2 (edit) |
ORF10 protein (edit) |
Hijack of Ubiquitination by SARS-CoV-2 (edit) |
SARS-CoV-2 (edit) |
Non-structural protein 9 [SARS-CoV-2] (edit) |
SARS-CoV-2 en COVID-19 pathway (edit) |
SARS-CoV-2 (edit) |
Non-structural protein 9 [SARS-CoV-2] (edit) |
Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex (edit) |
SARS-CoV-2 (edit) |
SARS-CoV-2 NSP9 complex (edit) |
SARS-CoV-2 en COVID-19 pathway (edit) |
SARS-CoV-2 (edit) |
SARS-CoV-2 Spike - human ACE2 receptor complex (edit) |
SARS-CoV-2 en COVID-19 pathway (edit) |
SARS-CoV-2 (edit) |
SARS-CoV-2 Spike - human ACE2-SLC6A19 complex (edit) |
SARS-CoV-2 en COVID-19 pathway (edit) |
SARS-CoV-2 (edit) |
SARS-CoV-2 cleaved Spike protein complex (edit) |
Linoleic acid metabolism affected by coronavirus infection (edit) |
SARS-CoV-2 (edit) |
SARS-CoV-2 cleaved Spike protein complex (edit) |
SARS-CoV-2 en COVID-19 pathway (edit) |
SARS-CoV-2 (edit) |
SARS-CoV-2 main protease complex (edit) |
SARS-CoV-2 en COVID-19 pathway (edit) |
SARS-CoV-2 (edit) |
SARS-CoV-2 NSP10-NSP16 2'-O-methyltransferase complex (edit) |
SARS-CoV-2 en COVID-19 pathway (edit) |
SARS-CoV-2 (edit) |
SARS-CoV-2 NSP3-NSP4-NSP6 complex (edit) |
SARS-CoV-2 en COVID-19 pathway (edit) |
SARS-CoV-2 (edit) |
Host translation inhibitor nsp1 [SARS-CoV-2] (edit) |
nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell (edit) |
SARS-CoV-2 (edit) |
Host translation inhibitor nsp1 [SARS-CoV-2] (edit) |
SARS-CoV-2 en COVID-19 pathway (edit) |
SARS-CoV-2 (edit) |
Non-structural protein 4 [SARS-CoV-2] (edit) |
SARS-CoV-2 en COVID-19 pathway (edit) |
SARS-CoV-2 (edit) |
Non-structural protein 7 [SARS-CoV-2] (edit) |
Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway (edit) |
SARS-CoV-2 (edit) |
Non-structural protein 7 [SARS-CoV-2] (edit) |
SARS-CoV-2 en COVID-19 pathway (edit) |